DexCom Inc., (DXCM) prominent player in the healthcare sector, specializes in continuous glucose monitoring systems, helping improve diabetes management. Listed on Nasdaq under the ticker “DXCM,” the company operates on a global scale.

This stock reflects a notable trading pattern, with anticipated market movements providing insights for investors. From a technical perspective, DXCM has been navigating a double three correction pattern since its November 2021 peak.

DXCM – Elliott Wave Latest Weekly View: 

The company’s grand super cycle ((I)) reached its zenith at $164.86, marking a high from its all-time low. Following this, the stock has exhibited a corrective wave ((II)), forecasting a gradual decline against the March-2024 high. Within wave ((I)), various smaller waves, such as (w), (x), & (y), have contributed to its dynamic movement. The stock recently broke below the (w) low, suggesting continued weakness towards $44.11 or lower levels—a critical point for investors.

Elliott Wave pattern suggest short-term strategies, such as selling during rebounds in three, seven, or eleven swings, as long as the stock remains below February-2025 high of $93.25, once it breaks below $62.34 low. Alternatively, if the stock surpasses $93.25 while holding above July-2024 low, a potential double correction could manifest. For long-term investments, the next blue box area in wave y might offer opportunities when the stock approaches this zone in the weekly chart. Navigating DXCM’s technical patterns demands careful observation & a strategic approach for investors aiming to capitalize on potential market movements.

Elliottwave Forecast updates 1-hour charts four times a day & 4-hour charts once a day for all our 78 instruments. We do a daily live session, where we guide our clients on the right side of the market. In addition, we have a chat room where our moderators will help you with any questions you have about what is happening in the market at the moment. You can try us for 14 days for only $9.99.